These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35968067)

  • 1. Prediction the survival of patients with breast cancer using random survival forests for competing risks.
    Najafi-Vosough R; Faradmal J; Tapak L; Alafchi B; Najafi-Ghobadi K; Mohammadi T
    J Prev Med Hyg; 2022 Jun; 63(2):E298-E303. PubMed ID: 35968067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors associated with major adverse cardiac and cerebrovascular events following percutaneous coronary intervention: a 10-year follow-up comparing random survival forest and Cox proportional-hazards model.
    Farhadian M; Dehdar Karsidani S; Mozayanimonfared A; Mahjub H
    BMC Cardiovasc Disord; 2021 Jan; 21(1):38. PubMed ID: 33461487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting the survival of patients with colorectal cancer using random survival forest.
    Roshanaei G; Safari M; Faradmal J; Abbasi M; Khazaei S
    J Gastrointest Cancer; 2022 Mar; 53(1):64-71. PubMed ID: 33174117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying Important Risk Factors for Survival in Kidney Graft Failure Patients Using Random Survival Forests.
    Hamidi O; Poorolajal J; Farhadian M; Tapak L
    Iran J Public Health; 2016 Jan; 45(1):27-33. PubMed ID: 27057518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of time to event analysis methods, using weight status and breast cancer as a case study.
    Aivaliotis G; Palczewski J; Atkinson R; Cade JE; Morris MA
    Sci Rep; 2021 Jul; 11(1):14058. PubMed ID: 34234154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel head and neck cancer survival analysis approach: random survival forests versus Cox proportional hazards regression.
    Datema FR; Moya A; Krause P; Bäck T; Willmes L; Langeveld T; Baatenburg de Jong RJ; Blom HM
    Head Neck; 2012 Jan; 34(1):50-8. PubMed ID: 21322080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual risk prediction: Comparing random forests with Cox proportional-hazards model by a simulation study.
    Baralou V; Kalpourtzi N; Touloumi G
    Biom J; 2023 Aug; 65(6):e2100380. PubMed ID: 36169048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the Factors Affecting Long-Term and Short-Term Survival of Breast Cancer Patients in Rafsanjan Using a Mixture Cure Model.
    Jahani S; Hoseini M; Pourhamid R; Askari M; Moslemi A
    J Res Health Sci; 2021 May; 21(2):e00516. PubMed ID: 34465639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying important risk factors for survival in patient with systolic heart failure using random survival forests.
    Hsich E; Gorodeski EZ; Blackstone EH; Ishwaran H; Lauer MS
    Circ Cardiovasc Qual Outcomes; 2011 Jan; 4(1):39-45. PubMed ID: 21098782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of forest methods for time-to-event data: variable selection and predictive performance.
    Liu Y; Zhou S; Wei H; An S
    BMC Med Res Methodol; 2021 Sep; 21(1):193. PubMed ID: 34563138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hazard models with and without consideration of competing risks to assess the effect of neoadjuvant chemotherapy on locoregional recurrence among breast cancer patients.
    Pathak M; S Deo SNV; Dwivedi SN; Vishnubhatla S; Thakur B
    J Cancer Res Ther; 2021; 17(4):982-987. PubMed ID: 34528552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis.
    Wulaningsih W; Vahdaninia M; Rowley M; Holmberg L; Garmo H; Malmstrom H; Lambe M; Hammar N; Walldius G; Jungner I; Coolen AC; Van Hemelrijck M
    BMC Cancer; 2015 Nov; 15():913. PubMed ID: 26577580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of mortality among hemodialysis patients in Hamadan province using random survival forests.
    Tapak L; Sheikh V; Jenabi E; Khazaei S
    J Prev Med Hyg; 2020 Sep; 61(3):E482-E488. PubMed ID: 33150237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Spatial Survival Model in Presence of Competing Risks for Iranian Gastrointestinal Cancer Patients.
    Hesam S; Mahmoudi M; Rahimi Foroushani A; Yaseri M; Mansournia MA
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2947-2954. PubMed ID: 30362330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis prediction of extremity and trunk wall soft-tissue sarcomas treated with surgical resection with radiomic analysis based on random survival forest.
    Yang Y; Ma X; Wang Y; Ding X
    Updates Surg; 2022 Feb; 74(1):355-365. PubMed ID: 34003477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival analysis of women with breast cancer: competing risk models.
    Ferraz RO; Moreira-Filho DC
    Cien Saude Colet; 2017 Nov; 22(11):3743-3754. PubMed ID: 29211179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Application and Comparison of Machine Learning Models for the Prediction of Breast Cancer Prognosis: Retrospective Cohort Study.
    Xiao J; Mo M; Wang Z; Zhou C; Shen J; Yuan J; He Y; Zheng Y
    JMIR Med Inform; 2022 Feb; 10(2):e33440. PubMed ID: 35179504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.
    de Glas NA; Kiderlen M; Vandenbroucke JP; de Craen AJ; Portielje JE; van de Velde CJ; Liefers GJ; Bastiaannet E; Le Cessie S
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26614095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
    Prat A; Guarneri V; Paré L; Griguolo G; Pascual T; Dieci MV; Chic N; González-Farré B; Frassoldati A; Sanfeliu E; Cejalvo JM; Muñoz M; Bisagni G; Brasó-Maristany F; Urso L; Vidal M; Brandes AA; Adamo B; Musolino A; Miglietta F; Conte B; Oliveira M; Saura C; Pernas S; Alarcón J; Llombart-Cussac A; Cortés J; Manso L; López R; Ciruelos E; Schettini F; Villagrasa P; Carey LA; Perou CM; Piacentini F; D'Amico R; Tagliafico E; Parker JS; Conte P
    Lancet Oncol; 2020 Nov; 21(11):1455-1464. PubMed ID: 33152285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival analysis of breast cancer patients using Cox and frailty models.
    Faradmal J; Talebi A; Rezaianzadeh A; Mahjub H
    J Res Health Sci; 2012 Dec; 12(2):127-30. PubMed ID: 23241526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.